Ex parte UGGE et al. - Page 9




          Appeal No. 1997-0601                                                        
          Application 08/161,878                                                      


          arguments not made separately for any individual claim or                   
          claims are considered waived.  See 37 CFR § 1. 192 (a) and                  
          (c).  In re Baxter Travenol Labs., 952 F.2d 388, 391, 21 USPQ               
          2d 1281, 1285 (Fed. Cir. 1991) (“It is not the function of                  
          this court to examine the claims in greater detail than argued              
          by an appellant, looking for nonobvious distinctions over the               
          prior art.”); In re Wiechert, 370 F.2d 927, 936, 152 USPQ 247,              
          254 (CCPA 1967) (“This court has uniformly followed the sound               
          rule that an issue raised below which is not argued in this                 
          court, even if it has been properly brought here by reason of               
          appeal is regarded as abandoned and will not be considered.                 
          It is our function as a court to decide disputed issues, not                
          to create them.”).                                                          
               We now treat the rejections before us.                                 
                             Claims 1, 2, 6, 12 and 16                                
               These claims are rejected under 35 U.S.C. § 103 as being               
          obvious over Ohta.  The Examiner contends [answer, pages 4 to               
          5 and 9 to 10] that Ohta (column 8) shows different size                    
          shorts for a two terminal device.  The Examiner asserts [id.                
          4] that “[i]t is considered that such different size shorts                 
          would have clearly been obvious in Ohta’s 3 terminal device.”               
                                         -9-                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007